A Study of Pitolisant in Participants With Prader-Willi Syndrome

NCT07219485 · clinicaltrials.gov ↗

PHASE3

Phase

ENROLLING_BY_INVITATION

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Prader-Willi Syndrome

Interventions

DRUG: Pitolisant

Sponsor

Harmony Biosciences Management, Inc.